يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Anti-Bacterial Agents analysis"', وقت الاستعلام: 1.74s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4

    المصدر: Bue, M, Tøttrup, M, Hanberg, P, Langhoff, O, Birke-Sørensen, H, Thillemann, T M, Andersson, T L & Søballe, K 2018, ' Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients ', Acta Orthopaedica, vol. 89, no. 1, pp. 95-100 . https://doi.org/10.1080/17453674.2017.1373497
    Acta Orthopaedica
    Acta Orthopaedica, Vol 89, Iss 1, Pp 95-100 (2018)

  5. 5

    المساهمون: Da Volterra [Paris, France], MetaGenoPolis, Institut National de la Recherche Agronomique (INRA), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Diderot, Sorbonne Paris Cité, Paris, France, Université Paris Diderot - Paris 7 (UPD7), Institut Gustave Roussy (IGR), Département de soins aigus [Gustave Roussy] (DSA), The randomized clinical trial was sponsored by Da Volterra (Paris) and funded in part by the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) under grant agreement number 282004, EvoTAR. Additional funding was from the Metagenopolis grant ANR-11-DPBS-0001, and from BPIFrance under the NOSOBIO collaborative program., We thank M. Ghidi and M. N. Bouverne (Da Volterra), as well as C. Féger (Emibiothech) for coordination and management of the clinical study, E. Arcaraz, E. Desmartin, A. Toutin, T. Mezzasalma, and C. Toutin (Amatsi Group) for the development and validation of bioanalytical methods, and for performing the fecal and plasma pharmacokinetic analyses, I. Wieder and C. Bourseau for performing the phenotypic microbiological analyses, Prof A. Dufour for biopharmacological analysis, P. Clerson (Orgamétrie) for statistical analysis of the clinical data, N. Galleron and B. Quinquis (Metagenopolis) for generating sequencing data, and P. Leonard (Metagenopolis) for informatics support., ANR-11-DPBS-0001,MGP,MetaGenoPolis(2011), European Project: 282004,EC:FP7:HEALTH,FP7-HEALTH-2011-single-stage,EVOTAR(2011), Kennedy, Sean, Démonstrateurs - MetaGenoPolis - - MGP2011 - ANR-11-DPBS-0001 - DPBS - VALID, Evolution and Transfer of Antibiotic Resistance - EVOTAR - - EC:FP7:HEALTH2011-10-01 - 2015-09-30 - 282004 - VALID, de Gunzburg, Jean, Ghozlane, Amine, Ducher, Annie, Mentré, France, Andremont, Antoine

    المصدر: Journal of Infectious Diseases
    Journal of Infectious Diseases, 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
    The Journal of Infectious Diseases
    Journal of Infectious Diseases, Oxford University Press (OUP), 2018, 217 (4), pp.628-636. ⟨10.1093/infdis/jix604⟩
    Journal of Infectious Diseases 4 (217), 628-636. (2018)

    مصطلحات موضوعية: 0301 basic medicine, Male, Antibiotics, Moxifloxacin, microbiome, MESH: Anti-Bacterial Agents/administration & dosage, MESH: Feces/chemistry, Pharmacology, antibiotics, law.invention, Feces, MESH: Aged, 80 and over, Randomized controlled trial, law, Immunology and Allergy, heterocyclic compounds, MESH: Healthy Volunteers, fluoroquinolones, MESH: Charcoal/administration & dosage, MESH: Gastrointestinal Microbiome/drug effects, MESH: Treatment Outcome, Aged, 80 and over, MESH: Aged, 0303 health sciences, MESH: Middle Aged, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Microbiota, Gastrointestinal Microbiome, MESH: Feces/microbiology, Middle Aged, Healthy Volunteers, 3. Good health, Anti-Bacterial Agents, Diarrhea, Infectious Diseases, Treatment Outcome, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, MESH: Young Adult, Charcoal, MESH: Anti-Bacterial Agents/analysis, Female, medicine.symptom, MESH: Metagenomics, medicine.drug, Adult, medicine.drug_class, 030106 microbiology, Médecine humaine et pathologie, Biology, Microbiology, 03 medical and health sciences, Major Articles and Brief Reports, Young Adult, medicine, Humans, Microbiome, Adverse effect, [SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology, 030304 developmental biology, Aged, Clostridium difficile, MESH: Humans, 030306 microbiology, business.industry, MESH: Adult, biochemical phenomena, metabolism, and nutrition, bacterial infections and mycoses, MESH: Moxifloxacin/analysis, MESH: Male, Clinical trial, MESH: Microbiota/drug effects, Regimen, 030104 developmental biology, Immunology, Human health and pathology, Metagenomics, MESH: Moxifloxacin/administration & dosage, business, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

    وصف الملف: application/pdf

  6. 6

    المصدر: PLOS ONE, Vol. 8 (2013) P. e53592
    PLoS ONE
    Plos One, vol. 8, no. 1, pp. e53592
    PLoS ONE, Vol 8, Iss 1, p e53592 (2013)

    وصف الملف: application/pdf

  7. 7

    المصدر: Journal of Clinical Microbiology, Vol. 48, No 6 (2010) pp. 2199-2204

  8. 8
  9. 9
  10. 10